- Home
- ENSC vs BNRG Comparison
ENSC vs BNRG Comparison
Compare ENSC & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- BNRG
- Stock Information
- Founded
- ENSC 2003
- BNRG 2012
- Country
- ENSC United States
- BNRG Israel
- Employees
- ENSC N/A
- BNRG N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- BNRG
- Sector
- ENSC Health Care
- BNRG
- Exchange
- ENSC Nasdaq
- BNRG Nasdaq
- Market Cap
- ENSC 5.2M
- BNRG 5.2M
- IPO Year
- ENSC N/A
- BNRG 2022
- Fundamental
- Price
- ENSC $2.14
- BNRG $2.06
- Analyst Decision
- ENSC
- BNRG
- Analyst Count
- ENSC 0
- BNRG 0
- Target Price
- ENSC N/A
- BNRG N/A
- AVG Volume (30 Days)
- ENSC 84.6K
- BNRG 72.8K
- Earning Date
- ENSC 08-13-2025
- BNRG 08-13-2025
- Dividend Yield
- ENSC N/A
- BNRG N/A
- EPS Growth
- ENSC N/A
- BNRG N/A
- EPS
- ENSC N/A
- BNRG N/A
- Revenue
- ENSC $7,413,722.00
- BNRG N/A
- Revenue This Year
- ENSC N/A
- BNRG N/A
- Revenue Next Year
- ENSC $1,354.55
- BNRG N/A
- P/E Ratio
- ENSC N/A
- BNRG N/A
- Revenue Growth
- ENSC 415.58
- BNRG N/A
- 52 Week Low
- ENSC $1.62
- BNRG $1.64
- 52 Week High
- ENSC $14.67
- BNRG $15.30
- Technical
- Relative Strength Index (RSI)
- ENSC 51.93
- BNRG 49.55
- Support Level
- ENSC $2.03
- BNRG $1.97
- Resistance Level
- ENSC $2.21
- BNRG $2.24
- Average True Range (ATR)
- ENSC 0.09
- BNRG 0.15
- MACD
- ENSC 0.01
- BNRG 0.01
- Stochastic Oscillator
- ENSC 63.38
- BNRG 21.95
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About BNRG Brenmiller Energy Ltd
Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.